子宫内膜息肉复发的高危因素研究进展
昆明医科大学第一附属医院, 云南昆明 650000
| 摘 要： | 子宫内膜息肉作为妇科常见的子宫内膜良性增生性疾病，尽管宫腔镜视野下子宫内膜息肉摘除术是该病的标准治疗手段，但其术后高复发率仍是临床诊疗的重点和难点。相关研究表明，息肉复发并非单一因素所致，而是涉及复杂且相关联的多因素协同作用机制。激素失衡、细胞增殖与凋亡失衡直接或间接促进子宫内膜息肉的形成。免疫失衡和炎症反应可能引起子宫内膜过度增生，而子宫内膜局部微环境的相关改变也与息肉形成密切相关。同时，代谢综合征相关疾病被证实是子宫内膜息肉复发的独立危险因素。然而，各高危因素与子宫内膜息肉高复发之间的关系及其交互作用仍需大样本多中心研究深入验证和阐明。本文系统阐述相关临床高危因素与子宫内膜息肉复发相关性及其临床高危因素潜在作用机制的最新研究进展，旨在为临床精准预防、早期干预子宫内膜息肉复发提供全面且坚实的理论基础，从而有效降低子宫内膜息肉的复发率，优化患者管理策略，改善预后并提升长期生存质量。 |
| 关 键 词： | 子宫内膜息肉; 复发; 高危因素 |
| DOI： | 10.57237/j.wjcm.2025.02.001 |
View:
Downloads:
收稿日期: 2025-05-12
接受日期: 2025-06-20
在线出版日期: 2025-10-16
Research Advances in High-Risk Factors for Recurrence of Endometrial Polyps
The First Affiliated Hospital of Kunming Medical University, Kunming 650000, China
| Abstract: | Endometrial polyps, as common benign endometrial hyperplastic disorders in gynecology, present a significant clinical challenge. Although polypectomy under hysteroscopic visualization is the standard treatment, the high postoperative recurrence rate remains a major focus and difficulty in clinical management. Relevant research indicates that polyp recurrence stems not from a single factor, but involves complex and interrelated multifactorial synergistic mechanisms. Hormonal imbalances and dysregulation of cellular proliferation and apoptosis directly or indirectly contribute to EP formation. Immune dysregulation and inflammatory responses may induce endometrial hyperplasia, while alterations in the local endometrial microenvironment are also closely associated with polyp development. Furthermore, components of metabolic syndrome have been confirmed as independent risk factors for EP recurrence. However, the relationships between these high-risk factors and the high recurrence rate of EPs, as well as their interactions, still require thorough validation and elucidation through large-scale, multicenter studies. This article systematically reviews the correlation between relevant clinical high-risk factors and EP recurrence, along with the latest research advances in their potential underlying mechanisms. It aims to establish a comprehensive and solid theoretical foundation for clinically precise prevention and early intervention against EP recurrence, ultimately aiming to effectively reduce the recurrence rate of endometrial polyps, optimize patient management strategies, improve prognosis, and enhance long-term quality of life. |
| Keywords: | Endometrial Polyps; Recurrence; High-Risk Factors |
参考文献
| [1] | 罗月明, 陈日利, 邱琤然. 210例子宫内膜息肉患者临床资料分析 [J]. 实用妇科内分泌电子杂志, 2023, 10(19): 14-16. |
| [2] | 朱兰, 李雷.子宫内膜息肉诊疗现状 [J]. 中国实用妇科与产科杂志, 2022, 38(3): 257-258. https://doi.org/10.19538/j.fk2022030101 |
| [3] | BERCEANU C, CERNEA N, CĂPITĂNESCU R G, et al.Endometrial polyps [J]. Rom J Morphol Embryol, 2022, 63(2): 323-334. https://doi.org/10.47162/RJME.63.2.04 |
| [4] | OZYURT R, TURKTEKIN N.Endometrial polyps prevent embryo implantation via creatine and lactate pathways [J]. Eur Rev Med Pharmacol Sci, 2022, 26(9): 3278-3281. https://doi.org/10.26355/eurrev_202205_28746 |
| [5] | PARADISI R, ROSSI S, SCIFO M C, et al.Recurrence of endometrial polyps [J]. Gynecol Obstet Invest, 2014, 78(1): 26-32. https://doi.org/10.1159/000362646 |
| [6] | 蒯丹, 唐清涛, 李小燕, 等.子宫内膜息肉发病机制研究进展 [J]. 生殖医学杂志, 2024, 33(8): 1109-1113. |
| [7] | 赵会娟, 申林林, 张亚琴, 等.子宫内膜息肉患者TRPC3和TRPC6蛋白表达的临床意义及与孕酮抵抗的相关性研究 [J]. 中国性科学, 2024, 33(7): 75-79. |
| [8] | 徐秀平, 邹小英, 王青飞.子宫内膜息肉宫腔镜术后复发的影响因素及预防措施 [J]. 牡丹江医学院学报, 2024, 45(2): 62-64+53. https://doi.org/10.13799/j.cnki.mdjyxyxb.2024.02.014 |
| [9] | 郭艳, 杨玲玲, 夏恩兰, 等. 宫腔镜子宫内膜息肉切除术后影响息肉复发的多因素分析: 手术时机的研究 [J]. 中国微创外科杂志, 2023, 23 (10): 726-730. |
| [10] | 望烨昕, 刘君, 何惠嫦, 等. 子宫内膜息肉复发的预测模型建立 [J/OL]. 实用妇科内分泌电子杂志, 2023, 10(7): 1-5 [2024-06-25]. https://doi.org/10.3969/j.issn.2095-8803.2023.07.001 |
| [11] | Dreisler E, Stampe Sorensen S, Ibsen PH, Lose G. Preva lence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol 2009; 33: 102-8. |
| [12] | 王欣.子宫内膜息肉术后复发的影响因素分析及地屈孕酮片与短效避孕药对其的预防作用研究 [J]. 中国医刊, 2023, 58(11): 1218-1223. |
| [13] | ONALAN R, ONALAN G, TONGUC E, et al.Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization [J]. Fertil Steril, 2009, 91(4): 1056-1060. |
| [14] | FERNANDEZ C J, GEORGE A S, SUBRAHMANYAN N A, et al.Epidemiological link between obesity, type 2 diabetes mellitus and cancer [J]. World J Methodol, 2021, 11(3): 23-45. https://doi.org/10.5662/wjm.v11.i3.23. |
| [15] | SERHAT E, COGENDEZ E, SELCUK S, et al.Is there a relationship between endometrial polyps and obesity, diabetes mellitus, hypertension? [J]. Arch Gynecol Obstet, 2014, 290: 937-941. |
| [16] | 李雪琳, 王菲凡, 彭丹红.子宫内膜息肉与胰岛素抵抗及PI3K、Akt蛋白表达的关系 [J]. 东南大学学报(医学版), 2022, 41(4): 562-565. |
| [17] | 张娟, 周生碧, 彭丽霞, 等.体重指数、腰臀比及胰岛素抵抗与绝经后子宫内膜息肉发病的相关性分析 [J]. 中国性科学, 2024, 33(2): 97-100. |
| [18] | DUN S, LIU C, LI N.Changes of vaginal microecology of women with intrauterine adhesions [J]. Int J Womens Health, 2023, 15: 857-867. https://doi.org/10.2147/IJWH.S407010 |
| [19] | KOSSAI M, PENAULT-LLORCA F.Role of hormones in common benign uterine lesions: endometrial polyps, leiomyomas, and adenomyosis [J]. Adv Exp Med Biol, 2020, 1242: 37-58. https://doi.org/10.1007/978-3-030-38474-6_3 |
| [20] | Yan C, Xing C, Wei T, Zhou H, Wang H, Liu T, Gao J. Impact of estrogen and progesterone receptor expression on the incidence of endometrial polyps. Biomark Med. 2023 Nov; 17(21): 881-887. https://doi.org/10.2217/bmm-2023-0411 |
| [21] | LIU Z, KUOKKANEN S, PAL L.Steroid hormone receptor profile of premenopausal endometrial polyps [J]. Reprod Sci, 2010, 17: 377-383. |
| [22] | 李秋辉, 蔡晓环, 郑晓惠.雌二醇/总睾酮预测子宫内膜息肉患者宫腔镜术后复发研究 [J]. 黑龙江医学, 2024, 48(14): 1710-1713. |
| [23] | RESLOVÁ T, TOSNER J, RESL M, et al.Endometrial polyps: a clinical study of 245 cases [J]. Arch Gynecol Obstet, 1999, 262(3-4): 133-139. |
| [24] | SAVELLI L, DE IACO P, SANTINI D, et al.Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps [J]. Am J Obstet Gynecol, 2003, 188(4): 927-931. |
| [25] | RYU K J, KIM M S, LEE J Y, et al.Risk of endometrial polyps, hyperplasia, carcinoma, and uterine cancer after tamoxifen treatment in premenopausal women with breast cancer [J]. JAMA Netw Open, 2022, 5(11): e2243951. https://doi.org/10.1001/jamanetworkopen.2022.43951 |
| [26] | 王江涛.乳腺癌术后抗雌激素类药物所致子宫内膜息肉患者的超声特征及VEGF、TGF-β1表达 [J]. 湖北科技学院学报 (医学版), 2023, 37(6): 527-529. https://doi.org/10.16751/j.cnki.2095-4646.2023.06.0527 |
| [27] | Leão RB, Andrade L, Vassalo J, Antunes A Jr, Pinto-Neto A, Costa-Paiva L. Differences in estrogen and progesterone receptor expression in endometrial polyps and atrophic endometrium of postmenopausal women with and without exposure to tamoxifen. Mol Clin Oncol. 2013 Nov; 1(6): 1055-1060. https://doi.org/10.3892/mco.2013.180 |
| [28] | Maja JH, Barbosa IC, Marques D, Calmon LC, Ladipo LC, Coutinho EM. Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacement therapy. J Am AssocGynecol Laparose. 1996; 4: 1318. |
| [29] | Cheng W-f, Lin H-H, Trong P-L, Huang S-C. Comparison of endometrial changes among symptomatic tamoxifen-treated and non-treated premenopausal and postmenopausal breast cancer patients. Gynaecol Oncol. 1997; 66: 233-7. |
| [30] | Reslova T, Tonsor J, Resi M, Kugler R, Vavrova I. Endometrial polyps-A clinical study of 245 cases. Arch Gynecol Obstet. 1999; 262: 3Z. |
| [31] | 罗祥力, 蔡芃夷.Ki-67和雌激素受体表达对育龄女性宫腔镜下子宫内膜息肉电切术后复发预测价值的研究 [J]. 中国性科学, 2022, 31(4): 121-125. |
| [32] | 倪莹.错配修复蛋白PMS2和MSH6表达与宫腔镜下子宫内膜息肉摘除术后复发的关系 [J]. 中国妇幼保健, 2023, 38(22): 4491-4495. https://doi.org/10.19829/j.zgfybj.issn.1001-4411.2023.22.049 |
| [33] | OLAVE M C, GRAHAM R P.Mismatch repair deficiency: the what, how and why it is important [J]. Genes Chromosomes Cancer, 2022, 61(6): 314-321. https://doi.org/10.1002/gcc.23015 |
| [34] | 申林林, 赵会娟, 张亚琴, 等.子宫内膜息肉组织中miR-152和miR-146b-5p的表达及意义 [J]. 国际检验医学杂志, 2024, 45(2): 238-242. |
| [35] | 夏艳霞, 王雪静.宫腔镜息肉电切术后miR-152及VEGF水平与复发的相关性 [J]. 浙江创伤外科, 2024, 29(7): 1221-1223+1227. |
| [36] | 李兰兰, 郝媛, 刘琰.子宫内膜息肉患者宫腔镜术后复发与NF-κB、PR、ERα和ERβ表达的关系 [J]. 临床医学研究与实践, 2022, 7(30): 16-19. https://doi.org/10.19347/j.cnki.2096-1413.202230005 |
| [37] | LIANG J, LI M, ZHANG L, et al.Analysis of the microbiota composition in the genital tract of infertile patients with chronic endometritis or endometrial polyps [J]. Front Cell Infect Microbiol, 2023, 13: 1125640. https://doi.org/10.3389/fcimb.2023.1125640 |
| [38] | KIM M J, LEE S, KWON M Y, et al.Clinical significance of composition and functional diversity of the vaginal microbiome in recurrent vaginitis [J]. Front Microbiol, 2022, 13: 851670. https://doi.org/10.3389/fmicb.2022.851670 |
| [39] | KOVALENKOVL, VOROPAEVA E E, KOZACHKOV E L, et al.Endometrial pathomorphology in bacterial vaginosis associated with chronic endometritis [J]. Arkh Patol, 2009, 70(2): 6-8. |
| [40] | 林苏云, 胡曙昉, 温莉虹, 等.子宫内膜息肉患者慢性子宫内膜炎发生情况及相关性分析 [J]. 中国计划生育学杂志, 2023, 31(12): 2937-2941. |
| [41] | Endometrial microbiota alteration in female patients with endometrial polyps based on 16S rRNA gene sequencing analysis [J]. Front Cell Infect Microbiol, 2024, 14: 1351329. https://doi.org/10.3389/fcimb.2024.1351329 |
| [42] | 姚静超, 叶丹萍, 金能, 等.接受宫腔镜治疗后子宫内膜息肉患者性激素炎症水平特征与复发的相关性分析 [J]. 中国妇幼保健, 2024, 39(16): 3045-3048. https://doi.org/10.19829/j.zgfybj.issn.1001-4411.2024.16.011 |
| [43] | KNAPP P, BARANOWSKI M, KNAPP M, et al.Altered sphingolipid metabolism in human endometrial cancer [J]. Prostaglandins Other Lipid Mediat, 2010, 92: 62-66. https://doi.org/10.1016/j.prostaglandins.2010.03.002 |
| [44] | LEE Y H, TAN C W, VENKATRATNAM A, et al.Dysregulated sphingolipid metabolism in endometriosis [J]. J Clin Endocrinol Metab, 2014, 99: E1913-E1921. https://doi.org/10.1210/jc.2014-1340 |
